Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

T. V. Kourelis; S. K. Kumar; G. Srivastava; M. A. Gertz; M. Q. Lacy; F. K. Buadi; R. A. Kyle; A. Dispenzieri

doi:10.1038/leu.2013.300

Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

T. V. Kourelis, S. K. Kumar, G. Srivastava, M. A. Gertz, M. Q. Lacy, F. K. Buadi, R. A. Kyle, A. Dispenzieri

Hematology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	455-457
Number of pages	3
Journal	Leukemia
Volume	28
Issue number	2
DOIs	https://doi.org/10.1038/leu.2013.300
State	Published - Feb 2014

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2013.300

Cite this

@article{122622be393344ad93086d5aa912936a,

title = "Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma",

author = "Kourelis, {T. V.} and Kumar, {S. K.} and G. Srivastava and Gertz, {M. A.} and Lacy, {M. Q.} and Buadi, {F. K.} and Kyle, {R. A.} and A. Dispenzieri",

note = "Funding Information: This work was supported in part by the JABBS Foundation, the Predolin Foundation and the Robert A Kyle Hematologic Malignancies Fund. Research funding was provided to Angela Dispenzieri by Celgene, Janssen Pharmaceuticals and Millennium Pharmaceuticals. Shaji K Kumar also received research funding from Celgene, Millennium Pharmaceuticals, Onyx.",

year = "2014",

month = feb,

doi = "10.1038/leu.2013.300",

language = "English (US)",

volume = "28",

pages = "455--457",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

AU - Kourelis, T. V.

AU - Kumar, S. K.

AU - Srivastava, G.

AU - Gertz, M. A.

AU - Lacy, M. Q.

AU - Buadi, F. K.

AU - Kyle, R. A.

AU - Dispenzieri, A.

N1 - Funding Information: This work was supported in part by the JABBS Foundation, the Predolin Foundation and the Robert A Kyle Hematologic Malignancies Fund. Research funding was provided to Angela Dispenzieri by Celgene, Janssen Pharmaceuticals and Millennium Pharmaceuticals. Shaji K Kumar also received research funding from Celgene, Millennium Pharmaceuticals, Onyx.

PY - 2014/2

Y1 - 2014/2

UR - http://www.scopus.com/inward/record.url?scp=84893720323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893720323&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.300

DO - 10.1038/leu.2013.300

M3 - Letter

C2 - 24150218

AN - SCOPUS:84893720323

SN - 0887-6924

VL - 28

SP - 455

EP - 457

JO - Leukemia

JF - Leukemia

IS - 2

ER -

Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this